SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 238 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,488,000 | -91.1% | 50,280 | -96.2% | 0.23% | -90.3% |
| Q4 2017 | $72,886,000 | +11.8% | 1,309,960 | -8.9% | 2.37% | +8.6% |
| Q3 2017 | $65,218,000 | -4.8% | 1,437,770 | -29.2% | 2.18% | -11.6% |
| Q2 2017 | $68,495,000 | +49.3% | 2,031,890 | +31.1% | 2.47% | +17.4% |
| Q1 2017 | $45,880,000 | +313.1% | 1,550,000 | +324.7% | 2.10% | +276.6% |
| Q2 2015 | $11,107,000 | +80.7% | 365,000 | -21.1% | 0.56% | +90.8% |
| Q1 2015 | $6,145,000 | -62.8% | 462,700 | +32.2% | 0.29% | -66.9% |
| Q3 2013 | $16,530,000 | – | 350,000 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |